Privo Technologies
Developing a novel, nanotechnology-based drug delivery platform capable of local and systemic delivery of a constant, controlled therapeutic dose through the mucosa. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€4—5m (Dealroom.co estimates Mar 2021.)
Peabody Massachusetts (HQ)
Authorizing premium user...